Hypertension, Vol 5, 682-688, Copyright © 1983 by American Heart Association
SW Lee, A Schwartz, RJ Adams, Y Yamori, K Whitmer, LK Lane and ET Wallick
Na+,K+-ATPase activity, phosphorylation, and [3H]ouabain binding in
sarcolemma isolated from spontaneously hypertensive rat (SHR) hearts were
compared to the same parameters in sarcolemma from normotensive rat (WKY)
hearts. Sarcolemma prepared from SHR heart contained significantly less
ouabain-inhibitable ATPase activity than sarcolemma from WKY heart. No
significant differences in sarcolemmal protein content or recovery were
noted between the two groups. The numbers of phosphorylation sites and
ouabain binding sites were lower for SHR hearts than for WKY hearts. The KD
values for ouabain binding were the same (0.30 muM) in cardiac sarcolemma
of SHR and WKY. The I50 values for inhibition by ouabain of Na+,K+-ATPase
were also the same for both groups (SHR = 49 microM; WKY = 44 microM).
These data suggest that the decrease of cardiac sarcolemmal Na+,K+-ATPase
activity in SHR hearts is due to a decrease in the number of active sites.
ARTICLES
Decrease in Na+,K+-ATPase activity and [3H]ouabain binding sites in sarcolemma prepared from hearts of spontaneously hypertensive rats
This article has been cited by other articles:
![]() |
M. Galinanes and A. G Fowler Role of clinical pathologies in myocardial injury following ischaemia and reperfusion Cardiovasc Res, February 15, 2004; 61(3): 512 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wolk Arrhythmogenic mechanisms in left ventricular hypertrophy Europace, January 1, 2000; 2(3): 216 - 223. [Abstract] [PDF] |
||||
![]() |
J. L. Lundmark, R. Ramasamy, P. R. Vulliet, and S. Schaefer Chelerythrine increases Na-K-ATPase activity and limits ischemic injury in isolated rat hearts Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H999 - H1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramasamy, H. Liu, P. J Oates, and S. Schaefer Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor Zopolrestat Cardiovasc Res, April 1, 1999; 42(1): 130 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rodriguez-Sargent, E. S. Estape, N. Fernandez, J. E. Irizarry, J. L. Cangiano, and O. A. Candia Altered Lens Short-Circuit Current in Adult Cataract-Prone Dahl Hypertensive Rats Hypertension, September 1, 1996; 28(3): 440 - 443. [Abstract] [Full Text] |
||||
![]() |
M. M. Pike, C. S. Luo, S. Yanagida, G. R. Hageman, and P. G. Anderson 23Na and 31P Nuclear Magnetic Resonance Studies of Ischemia-Induced Ventricular Fibrillation : Alterations of Intracellular Na+ and Cellular Energy Circ. Res., August 1, 1995; 77(2): 394 - 406. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |